Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

Irinotecan-containing doublet treatment versus irinotecan monotherapy as second-line choice for advanced gastric cancer

Abstract Background For patients with advanced gastric cancer (AGC), second-line chemotherapy regimen remains controversial. The efficacy and safety of irinotecan-containing doublet treatment and irinotecan monotherapy were compared in this systematic analysis. Methods A search was conducted on EMBA...

Full description

Bibliographic Details
Main Authors: Liuting Yang, Xiaoyue Jiang, Han Yan, Yingying Li, Hongchao Zhen, Bingmei Chang, Seyed Kariminia, Qin Li
Format: Article
Language:English
Published: BMC 2018-04-01
Series:BMC Gastroenterology
Subjects:
Irinotecan
Second-line chemotherapy
Advanced gastric cancer
Efficacy
Safety
Online Access:http://link.springer.com/article/10.1186/s12876-018-0772-4

Internet

http://link.springer.com/article/10.1186/s12876-018-0772-4

Similar Items